0 Комментарии
0 Поделились
6Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...0 Комментарии 0 Поделились 794 Просмотры 0 предпросмотр
-
Meningococcal Vaccines Market Analysis of Established and Emerging SegmentsThe Meningococcal Vaccines Market is projected to increase from USD 4.4 billion in 2026 to USD 5.9 billion by 2033, registering a CAGR of 4.5%. After reaching USD 4.1 billion in 2025, the Meningococcal Vaccines Market is entering a period in which growth opportunities vary considerably across vaccine brands, serogroups, age groups, and geographies. Rather than following one uniform trajectory,...0 Комментарии 0 Поделились 87 Просмотры 0 предпросмотр